Cargando…
Cloning of a Passage-Free SARS-CoV-2 Genome and Mutagenesis Using Red Recombination
The ongoing pandemic coronavirus (CoV) disease 2019 (COVID-19) by severe acute respiratory syndrome CoV-2 (SARS-CoV-2) has already caused substantial morbidity, mortality, and economic devastation. Reverse genetic approaches to generate recombinant viruses are a powerful tool to characterize and und...
Autores principales: | Herrmann, Alexandra, Jungnickl, Doris, Cordsmeier, Arne, Peter, Antonia Sophia, Überla, Klaus, Ensser, Armin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507965/ https://www.ncbi.nlm.nih.gov/pubmed/34638527 http://dx.doi.org/10.3390/ijms221910188 |
Ejemplares similares
-
Analysis of SARS-CoV-2 Spike Protein Variants with Recombinant Reporter Viruses Created from a Bacmid System
por: Cordsmeier, Arne, et al.
Publicado: (2023) -
Characterization of SARS-CoV-2 Escape Mutants to a Pair of Neutralizing Antibodies Targeting the RBD and the NTD
por: Peter, Antonia Sophia, et al.
Publicado: (2022) -
Methodological Development of a Multi-Readout Assay for the Assessment of Antiviral Drugs against SARS-CoV-2
por: Hahn, Friedrich, et al.
Publicado: (2021) -
Re-Analysis of the Widely Used Recombinant Murine Cytomegalovirus MCMV-m157luc Derived from the Bacmid pSM3fr Confirms Its Hybrid Nature
por: Cordsmeier, Arne, et al.
Publicado: (2023) -
SMYD2 Inhibition Downregulates TMPRSS2 and Decreases SARS-CoV-2 Infection in Human Intestinal and Airway Epithelial Cells
por: Yu, Yu-Qiang, et al.
Publicado: (2022)